Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherEndocrine and Diabetes

Blood glucose lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice

Michael Loffler, Martin Bilban, Mark Reimers, Werner Waldhausl and Thomas Stulnig
Journal of Pharmacology and Experimental Therapeutics October 31, 2005, DOI: https://doi.org/10.1124/jpet.105.093831
Michael Loffler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Bilban
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Reimers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Waldhausl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Stulnig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 365 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 365, Issue 2
1 May 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Blood glucose lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
OtherEndocrine and Diabetes

Blood glucose lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice

Michael Loffler, Martin Bilban, Mark Reimers, Werner Waldhausl and Thomas Stulnig
Journal of Pharmacology and Experimental Therapeutics October 31, 2005, DOI: https://doi.org/10.1124/jpet.105.093831

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherEndocrine and Diabetes

Blood glucose lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice

Michael Loffler, Martin Bilban, Mark Reimers, Werner Waldhausl and Thomas Stulnig
Journal of Pharmacology and Experimental Therapeutics October 31, 2005, DOI: https://doi.org/10.1124/jpet.105.093831
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Safety and Efficacy of the MetAP2 Inhibitor ZGN-1061
  • AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis
  • Protectin DX ameliorates hepatic steatosis by suppression of endoplasmic reticulum stress via AMPK-induced ORP150 expression
Show more Endocrine and Diabetes

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics